ALT and AST are each approximately log-linearly associated with CVD risk.
The associations are inverse and independent of conventional CVD risk factors.
The associations hold true across the normal ranges of the aminotransferases.
ALT or AST is unlikely to improve CVD risk assessment in the general population.